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Summary
Background Animals can act as a reservoir and source for the emergence of novel meticillin-resistant Staphylococcus 
aureus (MRSA) clones in human beings. Here, we report the discovery of a strain of S aureus (LGA251) isolated from 
bulk milk that was phenotypically resistant to meticillin but tested negative for the mecA gene and a preliminary 
investigation of the extent to which such strains are present in bovine and human populations.
Methods Isolates of bovine MRSA were obtained from the Veterinary Laboratories Agency in the UK, and isolates of 
human MRSA were obtained from diagnostic or reference laboratories (two in the UK and one in Denmark). From 
these collections, we searched for mecA PCR-negative bovine and human S aureus isolates showing phenotypic 
meticillin resistance. We used whole-genome sequencing to establish the genetic basis for the observed antibiotic 
resistance.
Findings A divergent mecA homologue (mecALGA251) was discovered in the LGA251 genome located in a novel 
staphylococcal cassette chromosome mec element, designated type-XI SCCmec. The mecALGA251 was 70% identical to 
S aureus mecA homologues and was initially detected in 15 S aureus isolates from dairy cattle in England. These 
isolates were from three diﬀ erent multilocus sequence type lineages (CC130, CC705, and ST425); spa type t843 
(associated with CC130) was identiﬁ ed in 60% of bovine isolates. When human mecA-negative MRSA isolates were 
tested, the mecALGA251 homologue was identiﬁ ed in 12 of 16 isolates from Scotland, 15 of 26 from England, and 24 of 32 
from Denmark. As in cows, t843 was the most common spa type detected in human beings.
Interpretation Although routine culture and antimicrobial susceptibility testing will identify S aureus isolates with this 
novel mecA homologue as meticillin resistant, present conﬁ rmatory methods will not identify them as MRSA. New 
diagnostic guidelines for the detection of MRSA should consider the inclusion of tests for mecALGA251.
Funding Department for Environment, Food and Rural Aﬀ airs, Higher Education Funding Council for England, Isaac 
Newton Trust (University of Cambridge), and the Wellcome Trust.
Introduction
Staphylococcus aureus causes a wide range of diseases in 
human beings, from minor skin infections to severe 
illnesses such as septicaemia, toxic shock, endocarditis, 
and pneumonia.1 First described in 1961, the increasing 
incidence of meticillin-resistant S aureus (MRSA), and its 
spread in hospitals and the community, has posed a 
major challenge for infectious disease medicine. The 
evolution of meticillin resistance in S aureus is, in part, 
conferred by the acquisition of one of several 
staphylococcal cassette chromosome mec elements 
(SCCmec),2 which carry a gene (mecA) that encodes a 
penicillin binding protein (PBP2a) with low aﬃ  nity for 
β-lactam antibiotics.3
Most isolates of MRSA in the UK are identiﬁ ed with 
antimicrobial susceptibility testing by measuring zones 
of growth inhibition around antibiotic-impregnated discs 
on agar plates or measurement of minimum inhibitory 
concentrations (MIC), as recommended by the British 
Society for Antimicrobial Chemotherapy guidelines.4 
Meticillin resistance breakpoints are zone diameters of 
14 mm or less around 1 μg oxacillin-impregnated discs, 
zone diameters of 21 mm or less around 10 μg cefoxitin-
impregnated discs, an oxacillin MIC of more than 
2 mg/L, or a cefoxitin MIC of more than 4 mg/L. 
Detection of the mecA gene by PCR or the detection of 
PBP2a in a slide agglutination assay5 can be used to 
conﬁ rm a diagnosis of MRSA when antimicrobial 
susceptibility results are borderline.
Before 2003, most MRSA identiﬁ ed belonged to 
multilocus sequence type clonal complexes (CC) 
associated with human carriage and infection. The 
emergence of MRSA CC398 (known as livestock-
associated MRSA) in farm animals and human beings 
has shown that some S aureus lineages might not be 
strongly host-species restricted.6 A survey of slaughter 
pigs in the Netherlands7 showed that 39% harboured 
MRSA sequence type (ST)398 and another survey8 
showed that 27% of people working at, or living on, 
a livestock farm in the Netherlands carried 
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livestock-associated MRSA. MRSA ST398 can cause 
infection in people, with close animal contact being the 
main risk factor,9 suggesting that farm animals could 
provide a reservoir of MRSA.
Here we report MRSA strains obtained from cattle and 
human beings, which carry a new SCCmec that is 
undetectable by molecular diagnostic tests used for 
identiﬁ cation of MRSA.
Methods
Bacterial isolates
S aureus LGA251 and S aureus LGA254 were isolated 
from a bulk milk sample from a farm in southwest 
England in May, 2007.10 24 MRSA were obtained from a 
collection of 940 S aureus isolates, submitted from 
465 diﬀ erent herds, after antibiotic susceptibility testing 
of all milk samples from cows with mastitis. The samples 
had been submitted to one of 14 regional Veterinary 
Laboratories Agency centres between April, 2006, and 
September, 2007, for bacteriological characterisation.11 
None of these isolates tested positive after standard PCR 
tests for mecA.11 MRSA isolated from human beings, as 
detailed in the webappendix (p 11), were provided by the 
Health Protection Agency (HPA; Addenbrooke’s 
Hospital, Cambridge, UK); the Staphylococcal Reference 
and Antibiotic Resistance Monitoring Laboratories, HPA 
(Colindale, London, UK); the Scottish MRSA Reference 
Laboratory (Glasgow, UK); and the National MRSA 
Reference Laboratory, Statens Serum Institut 
(Copenhagen, Denmark). Every centre identiﬁ ed likely 
candidate isolates for PCR testing for the 
mecA homologue, as detailed in the webappendix (p 11). 
Submission of all Danish MRSA to the Statens Serum 
Institut has been mandatory since November, 2006, and 
all MRSA and meticillin-susceptible S aureus submitted 
since 2007 have been spa typed; 678 isolates in 2007, 
857 in 2008, 817 in 2009, and 1090 in 2010 were MRSA.
Procedures
Species identiﬁ cation of selected isolates was conﬁ rmed 
by PCR with primers based on the 16S–23S rRNA spacer 
region for S aureus.12 Testing of strains for the presence 
of PBP2a was done with the Mastalex test (Mast Group, 
Bootle, UK), which is a slide agglutination assay that 
detects PBP2a in MRSA by use of latex sensitised with a 
monoclonal antibody directed against PBP2a.5 Molecular 
detection of mecA, femB, and the SCCmec–orfX junction 
was done with PCR, as described previously.13–18 A 
comparison of the primer sequences used to test 
for mecA and the target sequences in mecA and mecALGA251 
are shown in the webappendix (p 2). Isolates were 
genotyped for multilocus sequence type and spa type, as 
described previously.19,20
For all test isolates, the MIC of oxacillin and cefoxitin 
were measured by either Etest (AB Biodisk, Solna, 
Sweden) or agar dilution,21 depending on which 
laboratory did the test. The disc diﬀ usion technique 
was used to establish susceptibility of LGA251 
and LGA254 to penicillin, oxacillin, cefoxitin, 
gentamicin, neomycin, ciproﬂ oxacin, tetracycline, 
erythromycin, clindamycin, fusidic acid, chloram-
phenicol, teicoplanin, rifampicin, trimethoprim, 
linezolid, and mupirocin.22 To establish whether 
β-lactam resistance was a result of hyperproduction of 
β-lactamase, tests were done with and without adjacent 
discs impregnated with both amoxicillin and clavulanic 
acid.22 The S aureus NCTC 12493 strain was used as a 
control for MRSA and the S aureus NCTC 6571 strain 
was used as a control for meticillin-susceptible S aureus 
(both strains from the National Collection of Type 
Cultures, HPA, Salisbury, UK). Growth on chromogenic 
MRSA screening agar, MRSA ID (bioMérieux, 
Basingstoke, UK), was measured by standard plating 
and incubation for 18 h at 35°C.
We developed a PCR assay to amplify a region of 
mecA and the novel homologue described here, 
mecALGA251. Primers were based on conserved regions of 
the mecA sequences of previously described S aureus 
strains,23 S aureus LGA251, and other Staphylococcus 
species (Staphylococcus epidermidis, Staphylococcus sciuri, 
Staphylococcus vitulinus, Staphylococcus capitis, 
Staphylococcus kloosii, and Staphylococcus pseud-
intermedius). All the mecA sequences were aligned with 
Bioedit (Ibis Therapeutics, Carlsbad, USA). Primers were 
chosen from conserved regions with a GC proportion of 
40%. The chosen sequences were checked with Primer3 
(version 1.1.4) for melting temperatures and self-
complementarity,24 and pDraw32 (version 1.1.101) was 
used to conﬁ rm the amplicon size and melting 
temperatures. Primers were as follows: 
Fw, 5  ´ TCACCAGGTTCAAC[Y]CAAAA 3 ;´ and Rv, 
5  ´CCTGAATC[W]GCTAATAATATTTC 3 .´ Primers for 
the ampliﬁ cation of the femB control gene were obtained 
from a previously described protocol.13 A 25 μL PCR 
reaction contained ﬁ nal concentrations of 2·5 units of 
Taq DNA polymerase (Qiagen, Crawley, UK); 1xQ solution 
(Qiagen); 1xQiagen CoralLoad PCR buﬀ er (Tris-Cl, KCl, 
[NH4]2SO4, 15 mmol/L MgCl2, gel-loading reagent, orange 
dye, and red dye; pH 8·7; Qiagen); 4 mmol/L of MgCl2; 
0·8 mmol/L of each dNTP (GeneAmp, Applied 
Biosystems, Warrington, UK); 0·4 μmol/L of each primer 
(Operon, Cologne, Germany); and 50 ng of DNA 
template. A negative control, with no target DNA, was 
included in the PCR run in the GeneAmp PCR 
System 9700 (Applied Biosystems). The ampliﬁ cation 
programme consisted of an initial denaturation step at 
94°C for 5 min; 30 cycles of denaturing at 94°C for 1 min, 
annealing at 55°C for 1 min and extension at 72°C for 
2 min; and a ﬁ nal extension at 72°C for 5 min. PCR 
products were analysed by electrophoresis on a 1% 
agarose gel, previously stained with ethidium bromide at 
0·14 μg/mL (Sigma, Gillingham, UK), and run at 5 V/cm 
for 45 min. The molecular marker used was a 100 bp 
ladder (Promega, Southampton, UK). The sizes of the 
See Online for webappendix
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PCR products sequenced after PCR were 356 bp for the 
mecA gene, and 651 bp for the femB gene.
We designed a duplex-PCR to detect the mecA 
regulatory genes (primers: mecIF, 5´ 
GACACGTGAAGGCTATGATATAT 3 ;´ mecIR, 5´ 
ATTCTTCAATATCATCTTCGGAC 3 ;´ mecR1F, 5´ 
GGCTCAGTTAAATCATAAAGTTTG 3 ;´ mecR1R, 
5  ´AAATTGCCTTACCATAGCTTGTGT 3 )´, a duplex-PCR 
to identify the two cassette recombinase genes 
(primers: ccrAF, 5  ´GCAATAGGTTATCTACGTCAAAG 3 ;´ 
ccrAR, 5´ TCTAATGATTGTGCGTTGATTCC 3 ;´ ccrBF, 
5  ´ TTCGTGTATCGACAGAAATGCAG 3 ;´ ccrBR, 
5  ´ CATCTTTACGAATATCAATACGG 3 )´, and a single 
target PCR to amplify the β-lactamase gene blaZ (primers: 
blaZF, 5  ´ AGTCGTGTTAGCGTTGATATTAA 3 ;´ blaZR, 
5  ´ CAATTTCAGCAACCTCACTTACTA 3 )´. The sizes of 
the expected PCR products were 344 bp for mecI, 710 bp for 
mecR1, 932 bp for ccrA, 1449 bp for ccrB, and 809 bp 
for blaZ. Except for use of an annealing temperature of 
58°C instead of 55°C, we used the same method as for the 
other PCR assay described above.
The whole genome of the S aureus isolate LGA251 was 
sequenced with both capillary sequencing (on ABI 3730xl 
analysers; Applied Biosystems) and pyrosequencing (on 
454 instruments; Life Sciences, Roche Diagnostics 
Corporation, Branford, CT, USA). A total of 29 300 high 
quality capillary reads were produced mostly from two 
subclone libraries (a 2–3 kb insert library and a 3–4 kb 
library, both with the vector pOTW12). The average read 
length was 650 bp and these reads represented 6·8 times 
coverage. The 454 sequencing produced 59·07 Mb data 
in reads with an average length of 225 bp. The assembly 
of these reads with Newbler 1.1.03.24 gave 81 contigs 
greater than 500 bp with a combined length of 
2 699 627 bp in six scaﬀ olds.
A combined assembly of the capillary reads, with Phrap 
(Version 17.0), and the consensus sequences from the 
454 assembly (which were converted into overlapping 
500 bp sequences) produced 26 contigs (overlapping 
sequences or clones from which a sequence can be 
obtained) greater than 2 kb with an N50 of 532 kb. A 
further 2310 high quality reads were produced to close 
gaps and to improve the quality of the sequence to ﬁ nished 
standard. The sequence was ﬁ nished and annotated as 
described previously.25 The sequences and annotations of 
the S aureus strain LGA251 genome have been entered in 
the EMBL database (accession numbers FR821779 for the 
chromosome and FR821780 for the plasmid).
Statistical analysis
Temporal trends for annual incidence of detection of 
mecALGA251 in Denmark for the years 2007–10, with all 
MRSA as the denominator, were assessed with the 
Cochran-Armitage trend test. Statistical analysis was 
done with StatXact version 9.
Role of the funding sources
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Figure 1: Comparison of the type XI SCCmec of LGA251 with other SCC elements
Schematic diagram of type II SCCmec of meticillin-resistant Staphylococcus aureus MRSA252 (top), type IV SCCmec of MW2 (upper middle), type XI SCCmec of LGA251 (lower middle), and the SCCmec-
like element of Macrococcus caseolyticus JCSC7096 (bottom). The names of the coding sequences associated with drug and metal resistance are provided. Coding sequences are marked in the direction 
of transcription as arrows. Coding sequences belonging to the mec and ccr complexes, and IS431 are coloured, with homologues given the same colour; the individual genes belonging to these groups 
are named. Light pink shading joins regions that are conserved between elements. The coloured boxes at the end of the SCC elements mark the integration site sequence (blue, attL; green attR).
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Results
LGA251 was resistant to penicillin, oxacillin, and cefoxitin, 
but susceptible to gentamicin, neomycin, ciproﬂ oxacin, 
tetracycline, erythromycin, clindamycin, fusidic acid, 
chloramphenicol, teicoplanin, rifampicin, trimethoprim, 
linezolid, and mupirocin. LGA251 gave negative reactions 
in the latex agglutination test for PBP2a, a PCR assay with 
primers for mecA,13 and a PCR that ampliﬁ es a region of 
the SCCmec (SCCmec-orfX).18 Culture of LGA251 on agar 
plates with and without adjacent discs impregnated with 
both amoxicillin and clavulanic acid indicated that 
resistance was not mediated by β-lactamase hyper-
production (webappendix p 4). LGA254 had cefoxitin 
MICs of 24 mg/L and oxacillin Etest (AB Biodisk NA, 
Culver City, CA, USA) MICs of 12 mg/L, and although 
resistant to penicillin, was susceptible to gentamicin, 
neomycin, ciproﬂ oxacin, tetracycline, erythromycin, 
clindamycin, fusidic acid, chloramphenicol, teicoplanin, 
rifampicin, trimethoprim, linezolid, and mupirocin. 
Both LGA251 and LGA254 were sequence type 425 by 
multilocus sequence type but the spa type of LGA251 
was t6300 (spa repeat: 14-44-12-17-23-18-110-17-17-23-24) 
and  the spa type of LGA254 was t6292 (spa repeat: 14-44-
12-17-23-18-110-17-17-17-23-24).
The genetic basis of the meticillin resistance in 
LGA251 was investigated by whole-genome sequencing. 
Host Location Sample Year Multilocus 
sequence type
Clonal 
complex
spa type Oxacillin MIC (mg/L) Cefoxitin MIC (mg/L)
LGA251 Bovine Somerset, England Bulk milk 2007 425 425 t6300 16 32
LGA254 Bovine Somerset, England Bulk milk 2007 425 425 t6292 12 24
C02 467 Bovine Bury St Edmunds, England Milk 2006–07 130 130 t6220 32 12
C02 937 Bovine Langford, England Milk 2006–07 425 425 t6292 16 12
C03 125 Bovine Bury St Edmunds, England Milk 2006–07 1245 130 t843 16 32
C03 362 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 2 12
C03 363 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 24
C03 364 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 12
C03 365 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 24
C03 366 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 12
C03 367 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 12
C03 370 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 32
C03 371 Bovine Sutton Bonington, England Milk 2006–07 1245 130 t843 16 24
C04 288 Bovine Thirsk, England Milk 2006–07 1526 130 t6293 8 32
C04 831 Bovine Truro, England Milk 2006–07 151 705 t529 16 4
SA227 Human Cambridge, England Unknown 2008 130 130 t1736 16 32
02.5099.D Human Tayside, Scotland Finger 2002 1944 130 t843 24 32
08.6601.A Human Lothian, Scotland Nose 2008 1245 130 t1535 32 24
09.2364.C Human Ayrshire and Arran, Scotland Nose 2009 1245 130 t7947 24 32
09.3741.Aa Human Western Isles, Scotland Wound 2009 130 130 t843 8 16
09.4633.Ca Human Highland, Scotland Nose 2009 1764 130 t7485 32 16
09.4657.D Human Grampian, Scotland Wound 2009 1764 130 t7485 16 24
09.7342.H Human Grampian, Scotland Blood 2009 130 130 t843 16 24
09.8549.Q Human Highland , Scotland Wound 2009 1764 130 t7485 32 32
10.1799.W Human Tayside, Scotland Screen 2010 1245 130 t7946 16 16
10.3514.K Human Greater Glasgow and Clyde, Scotland PEG site 2010 1943 1943 t7945 32 48
10.4264.V Human Ayrshire and Arran, Scotland Toe 2010 130 130 t843 32 32
10.7365.L Human Greater Glasgow and Clyde, Scotland Hand 2010 130 130 t843 16 16
H052960441 Human East England Not known 2005 130 130 t843 16 64
H061860351 Human Northwest England Sputum 2006 130 130 t843 16 16
H074300388 Human Northwest of england Skin swab 2007 130 130 t843 16 64
H091100226 Human East England Skin swab 2009 425 425 t6386 16 32
H092840495 Human Northeast England Nose screen 2009 1526 130 t6293 8 8
H093880936 Human Southeast England Ear swab 2009 425 425 t742 16 64
H101740629 Human Northwest England Skin swab 2010 130 130 t7734 16 16
H102840444 Human Southwest England Nose screen 2010 425 425 t742 8 32
H103360314 Human Northwest England Nose screen 2010 1945 130 t1535 16 16
H104700070 Human Yorkshire and Humber, England Nose screen 2010 130 130 t843 16 4
(Continues on next page)
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Comparative analysis of the 2·8 Mb genome revealed a 
29·4 kb SCCmec element inserted in the chromosome 
at the same locus (3´region of orfX) as other SCCmec 
elements, ﬂ anked by sequences that match the SCC 
integration site sequence.26 The element contained 
29 coding sequences, including homologues of the site-
speciﬁ c recombinase genes ccrA and ccrB, and the 
mecA gene encoding the penicillin-binding protein 
PBP2a (ﬁ gure 1).
The site-speciﬁ c recombinases CcrA and CcrB were 
divergent by comparison with those encoded by other 
SCCmec elements; CcrA was classiﬁ ed as ccrA1 group 
and CcrB was classiﬁ ed as ccrB3 group (webappendix 
p 13). The combination of ccrA1 and ccrB3 is novel and 
has been designated as type-8 ccr.
Comparison of the PBP2a encoded by the LGA251 
mecA (MecALGA251) with proteins in the public sequence 
databases (Universal Protein Resource; UniProt) 
indicated that it is divergent in comparison with all 
other MecA homologues; MecALGA251 was most similar to 
MecA from the type III SCCmec (accession number 
Q93IC2), having 63% identity at the aminoacid level 
(70% at the DNA level; webappendix p 13). Phylogenetic 
analysis of MecALGA251 showed that it belongs to the 
PBP2a family (data not shown) and is found on a branch 
outside the clade that includes S aureus homologues 
and homologues from other Staphylococcus species 
(webappendix p 6).
The mecALGA251 gene was part of a complex (mecI–mecR1–
mecA–blaZ) that has a diﬀ erent organisation to other 
SCCmec elements, and has been designated as class E 
mec gene complex. A complex with the same organisation 
has been identiﬁ ed in a plasmid,27 and an SCCmec-like 
element carried by Macrococcus caseolyticus,28 although 
the sequence conservation of the two complexes is low 
(<60% identity at the DNA level).
The LGA251 SCCmec element was novel and holds only 
two of the three joining regions normally seen (J1 and J2; 
For more on UniProt see 
http://www.uniprot.org/
Host Location Sample Year Multilocus 
sequence type
Clonal 
complex
spa type Oxacillin MIC (mg/L) Cefoxitin MIC (mg/L)
(Continued from previous page)
H104720074 Human Yorkshire and Humber , England Nose screen 2010 130 130 t843 16 4
H105020135 Human East Midlands, England Nose screen 2010 1945 130 t843 8 4
H105060288 Human West Midlands, England Nose screen 2010 1945 130 t843 8 4
H105140339 Human Southwest England Nose screen 2010 1946 1943 t978 16 4
43066 Human Næstved, Denmark Wound 2004 130 130 t843 2 16
43067 Human Næstved, Denmark Wound 2004 130 130 t843 16 32
45454 Human Herlev, Denmark Skin 2005 130 130 t843 6 16
47034 Human Herlev, Denmark Unknown 2005 130 130 t843 6 32
61425 Human Viborg, Denmark Blood 2008 130 130 t843 3 12
65727 Human Sønderborg, Denmark Nose/mouth 2009 n/d 130 t843 16 64
66519 Human SSI, Denmark SSTI 2009 n/d 130 t843 8 8
66712 Human Aalborg, Denmark SSTI 2009 130 130 t843 4 16
67909 Human Vejle, Denmark SSTI 2009 n/d 130 t843 0·75 8
70355 Human Hillerød, Denmark Nose/mouth 2010 130 130 t843 4 24
70782 Human Slagelse, Denmark Eye/ear 2010 n/d 130 t843 6 32
70956 Human Slagelse, Denmark SSTI 2010 n/d 130 t843 4 48
71274 Human Slagelse, Denmark Blood 2010 n/d 130 t843 12 32
71795 Human Slagelse, Denmark SSTI 2010 n/d 130 t843 1·5 8
71950 Human Aalborg, Denmark Eye/ear 2010 n/d 130 t843 16 64
71957 Human Slagelse, Denmark Unknown 2010 n/d 130 t843 1·5 16
72270 Human Nykbøbing F, Denmark Screening 2010 n/d 130 t843 6 24
72890 Human Aalborg , Denmark SSTI 2010 n/d 130 t843 24 48
72976 Human Vejle, Denmark Fluid 2010 n/d 130 t843 4 16
73532 Human Herning, Denmark SSTI 2010 n/d 130 t843 4 16
73760 Human Hillerød, Denmark Blood 2010 n/d 130 t843 16 64
73829 Human Vejle, Denmark Unknown 2010 n/d 130 t843 8 16
75022 Human Slagelse, Denmark Unknown 2011 n/d 130 t1535 12 32
Enr.7594/75 Human SSI, Denmark Blood 1975 n/d 130 t843 3 16
PEG=percutaneous endoscopic gastrostomy. SSI=Statens Serum Institut. SSTI=skin and soft tissue infection. MIC=minimum inhibitory concentration. n/d=not done (clonal complexes for these isolates are 
predictions based on spa type).
Table: Data for all bovine and human meticillin-resistant Staphylococcus aureus strains with the mecALGA251 gene, by isolate
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ﬁ gure 1). The blaZ gene was located at the left hand end 
of the element in a J3 region, but has been designated as 
part of the class E mec gene complex. The J2 region 
contained genes encoding hypothetical, exported, and 
membrane proteins, and the J1 region contained 
hypothetical proteins, an exported protein, membrane 
proteins, a lipase gene fragment, ABC transporter 
proteins, and genes associated with arsenic resistance. 
The sequence was submitted to the International 
Working Group on the Classiﬁ cation of SCC29 and has 
been given the designation type XI SCCmec.
Details of the geographical distribution, year of isolation, 
and test results for the bovine isolates are included in the 
table and ﬁ gure 2. More than half (13 of 24; 54%) of the 
MRSA isolates from the survey done by the Veterinary 
Laboratories Agency were positive by PCR for the 
mecALGA251 gene and for the mecI, mecR1, ccrA, ccrB, and 
blaZ genes of type XI SCCmec. Sequencing of the mecA 
PCR amplicons from the 13 positive S aureus showed that 
these isolates had an identical sequence to that of mecALGA251. 
The 13 mecALGA251-positive S aureus isolates were genotyped 
by multilocus sequence type and spa type. One strain was 
the same sequence type as LGA251 (ST 425), the remainder 
resolved into four diﬀ erent sequence types.
Searches for human MRSA isolates yielded 51 isolates 
that tested positive by PCR for mecALGA251 from likely 
candidates of about 120 000 clinical isolates: the only one 
tested from Cambridge, 14 of 25 tested from London, 
12 of 16 tested from Glasgow, and 24 of 32 tested from 
Copenhagen. The results of tests are listed in the table 
and the geographical distribution of the mecALGA251 isolates 
is shown in ﬁ gure 2 for England and in the webappendix 
for Scotland (p 7) and Denmark (p 8). The oxacillin MICs 
ranged from 0·75 mg/L to 32 mg/L, with an MIC50 of 
4 mg/L and MIC90 of 16 mg/L. The cefoxitin MICs ranged 
from 4 mg/L to 64 mg/L, with an MIC50 of 8 mg/L and 
MIC90 of 24 mg/L. All the British isolates were multilocus 
sequence typed together with seven of 24 Danish isolates. 
In the Danish isolates mecALGA251 was detected in none of 
678 isolates in 2007, one of 857 isolates in 2008 (0·12%, 
95% CI 0–0·35%), four of 817 isolates in 2009 (0·49%, 
0·01–0·97), and 13 of 1090 isolates (0·67%, 0·61–1·95) in 
2010 (trend for increase: p=0·0002).
The evolutionary relation of the MRSA sequence types 
that carry mecALGA251 was compared within this population 
and with the S aureus population as a whole, considering 
the most frequently reported sequence types (ten or more 
isolates reported per sequence type).30 Analysis of the 
population framework shows that mecALGA251 homologues 
are present in phylogenetically distinct S aureus, 
indicating that multiple independent acquisitions of the 
gene have occurred (webappendix p 9).
Discussion
A novel mecA homologue, mecALGA251, associated with 
resistance to β-lactam antibiotics was present in clinical 
MRSA isolates from the UK and Denmark, and bovine 
milk samples from the UK. Our search for mecALGA251 
MRSA has been limited to existing collections comprising 
isolates collected for various reasons and for which 
incomplete clinical data or strain typing were available. 
Therefore, interpretations made from our results are 
tentative and need to be conﬁ rmed by more systematic 
studies with appropriate methodology.
The detection of this gene in MRSA isolates cultured 
from blood and infected wound sites is strong 
circumstantial evidence that these organisms are capable 
of causing clinical disease. Whether disease caused by 
mecALGA251 S aureus is identical to that caused by 
conventional MRSA is not clear without evidence from 
formal epidemiological and virulence studies. Isolate 
collections were systematically searched for isolates that 
seemed to be β-lactam resistant, but tested negative by 
PCR for mecA or by slide agglutination test for PBP2a, 
and from a search for MRSA isolates that had spa types 
associated with mecALGA251 MRSA (webappendix p 11). The 
Danish isolate archive is a complete national collection. 
These results reveal that detection rates of mecALGA251 
MRSA increased substantially between 2007 and 2010. 
These detection rates are good incidence estimates for 
those years in Denmark because the archive for 2007–10 
contains all Danish MRSA, and because all MRSA 
isolates were spa-typed.
Figure 2: Geographical distribution of the bovine and human meticillin-resistant Staphylococcus aureus 
strains carrying the mecALGA251 gene in England
The colouring of the symbols and labels indicates common lineage, deﬁ ned on the basis of spa typing, multilocus 
sequence typing, or both. spa types and multilocus sequence types are indicated in the labels.
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In this study, we provide evidence of an association 
between SCCmecLGA251 and β-lactam resistance—which 
includes meticillin resistance—in S aureus. Genetic 
manipulation of S aureus strains to show that the insertion 
or removal of the mecA homologue leads to acquisition or 
loss of β-lactam resistance will need to be done to show 
direct linkage, and such studies are underway. However, 
we were able to search the entire genome of LGA251 for 
evidence of other genes that might confer resistance. 
Although a β-lactamase gene (blaZ) is present in 
SCCmecLGA251 the inability of clavulanate (a β-lactamase 
inhibitor) to ablate resistance indicates that resistance is 
unlikely to be caused by β-lactamase. This ﬁ nding is 
consistent with the fact that penicillinase hyperproducers 
do not show heteroresistance,31 as was seen with LGA251 
(panel). The expected complement of genes that encode 
PBP is present (PBP1, PBP2, PBP3, and PBP4) in a highly 
conserved form compared with other sequences from 
other S aureus isolates (data not shown), and we recorded 
no additional PBPs. The most likely explanation for the 
β-lactam resistance seen in LGA251 is that it is mediated 
by the mecA homologue present in the type XI SCCmec.
The discovery of this new mecA homologue raises issues 
about the detection and conﬁ rmation of MRSA. 
Irrespective of whether an infection is caused by mecALGA251 
MRSA or conventional MRSA, after culture and 
antimicrobial susceptibility testing, appropriate decisions 
about care of patients can be made. However, when 
existing PCR or monoclonal antibody methods are used as 
the only method to detect MRSA, or when these methods 
are used to conﬁ rm provisional detection of MRSA, then 
mecALGA251 S aureus will be wrongly diagnosed as meticillin 
susceptible. The use of new PCR primers such as those 
described in this paper, and the production of new 
monoclonal antibodies, would address this problem.
Another important question concerns the potential role 
of cattle in the epidemiology of human MRSA infections 
caused by mecALGA251 MRSA. Data from the Veterinary 
Laboratories Agency MRSA survey suggest that mecALGA251 
could be present in up to 1·4% (95% CI 0·6–2·1%) of 
S aureus bovine mastitis isolates, and is present in up to 
2·8 % (1·3–4·3) of herds. The data described in this 
paper do not provide direct evidence of transmission 
between cattle and people. However, four pieces of 
circumstantial evidence suggest that cattle could be the 
epidemiological source. First, the human isolate strain 
types were either CC130 (48 of 66)—a lineage that is 
thought to be unique to animals32—or other strain types 
detected in cattle during this study and not previously 
reported in human beings. Second, none of the strain 
types or spa-types carrying mecALGA251 come from lineages 
previously associated with human MRSA carriage or 
infection. Third, in England, where data from both cattle 
and human beings are available, evidence of geographical 
association in both human and bovine isolates exists (ie, 
human and bovine ST425 in the southwest, human and 
bovine ST130 in the east, and human and bovine ST1526 
in the northeast; ﬁ gure 2). Fourth, the Veterinary 
Laboratories Agency survey looking for MRSA in dairy 
cattle noted no other (ie, human) MRSA,11 although there 
are infrequent reports of human-associated lineages of 
mecA-positive MRSA causing mastitis in cattle in other 
countries.33 Such evidence suggests that a bovine reservoir 
exists, from which mecALGA251 MRSA is transmitted to 
people. Pasteurisation of milk will prevent any risk of 
infection via the food chain but individuals in close 
contact with cattle could be at higher risk of carriage. 
Further research is needed to test this hypothesis.
The absence of diversity between the mecALGA251 S aureus 
isolates from Denmark and those from the UK could be a 
result of a searching bias (ie, that spa-type t843 was used 
as one of the searching criteria, and by testing for known 
spa types only we might have missed mecALGA251 MRSA 
that had diﬀ erent spa types). The discovery of an isolate 
from a sample obtained from a patient in 1975 possessing 
the same spa-type shows that the mecA homologue has 
been in S aureus for at least 36 years, and that the Danish 
lineage could have changed very little during this period. 
This early Danish isolate also suggests that mecALGA251 
S aureus might have originally been a human strain. The 
presence of type XI SCCmec in four separate multilocus 
sequence type lineages, and the fact that it is bounded by 
integration site sequence repeats and has intact site-
speciﬁ c recombination components, suggests that it has 
the potential to be transferred to other S aureus lineages 
in the future.
The search for mecALGA251 MRSA also yielded several 
isolates that had an MRSA phenotype but no mecA gene 
Panel: Research in context
Systematic review
The discovery of a novel mecA homologue prompted a search of public sequence 
databases (UniProt) with the predicted aminoacid sequence for similar mecA 
homologues. No identical sequence was found and the closest match had 63% identity at 
the aminoacid level. We searched PubMed with the terms “cattle”, “MRSA”, “livestock”, 
and “MRSA” for any evidence of livestock-associated meticillin-resistant S aureus (MRSA) 
that were not accounted for by known SCCmec types. None were found.
Interpretation
Advice on the detection and treatment of infections with mecALGA251 MRSA by antimicrobial 
susceptibility testing is no diﬀ erent to the detection and treatment of infections with 
other MRSA strains. However, clinicians should be aware that molecular techniques of 
detection of MRSA with PCR or slide agglutination tests do not detect mecALGA251 MRSA. 
This means that when these tests are used either for primary detection, or for conﬁ rmation 
of MRSA, a small chance exists that a false-negative result is obtained. The data presented 
in this paper suggest that the prevalence of mecALGA251 MRSA is likely to be in the range of 
one in 100 to one in 500 of total MRSA in the UK and Denmark. The discovery of the same 
mecALGA251 MRSA in dairy cows suggests that these animals might provide a reservoir of 
infection and close links with farms or contact with dairy cattle could be risk factors that 
increase the likelihood of mecALGA251 MRSA carriage or infection in patients. Until better 
evidence is generated from appropriate observational or experimental studies, this study 
provides the best evidence to inform clinical decisions concerning this new discovery.
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that could be detected by PCR. These isolates might 
possess other mecA homologues or other mechanisms 
leading to β-lactam resistance. The discovery of this 
previously undetected mecA homologue is potentially of 
public health importance. Diagnostic protocols, whether 
for clinical or epidemiological purposes, should consider 
the ramiﬁ cations of not detecting S aureus strains that 
carry this new mecA homologue.
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